• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Eli Lilly

Eli Lilly

Eli Lilly and Co LLY 3 Star

Last Price$64.25Day Change (%)0.83%
Open Price$63.93Day Change ($)0.53
Day Range63.80–64.4452-Week Range47.53–64.44

As of Wed 07/23/2014 05:35 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company

    Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company

  2. Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus

    Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus

  3. New Data Shows Cognitive Impairment Precedes and Predicts Subsequent Functional Impairment in Patients with Mild Alzheimer's Disease

    New Data Shows Cognitive Impairment Precedes and Predicts Subsequent Functional Impairment in Patients with Mild Alzheimer's Disease

  4. New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice

    New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice

  5. Research and Markets: PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

    Research and Markets: PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  6. Research and Markets: U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014

    Research and Markets: U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014

  7. Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement

    Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement

  8. Research and Markets: UK Insulin Delivery Devices Market Analysis - Size, Share, Growth, Trends and Forecast Through 2006 - 2019

    Research and Markets: UK Insulin Delivery Devices Market Analysis - Size, Share, Growth, Trends and Forecast Through 2006 - 2019

  9. Research and Markets: Global Animal Growth Promoters and Performance Enhancers Market Report 2014-2018

    Research and Markets: Global Animal Growth Promoters and Performance Enhancers Market Report 2014-2018

  10. SEC, FINRA Enforcement Roundup: Eli Lilly to Pay $29M to Settle Foreign Bribery Charges

    The SEC recently charged Eli Lilly for violations of the FCPA and barred an Arizona-based fund manager from the industry after the fund’s collapse. FINRA ordered Pruco Securities to pay $10.7 million.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.